Sponsor:
Alexion Pharmaceuticals, Inc.
Code:
NCT05746559
Conditions
Chronic Kidney Disease
CKD
Cardiac Disease
Cardiopulmonary Bypass
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Placebo
Ravulizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Alexion Pharmaceuticals, Inc. on 2025-05-21.